The role of oxidized lipoproteins in atherogenesis

Free Radical Biology and Medicine

Volumn 20, Issue 5, 1996, Pages 707-727

  Berliner, Judith A ^a   Heinecke, Jay W ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b WASHINGTON UNIVERSITY   (United States)

Author keywords

Antioxidant; Atherosclerosis; Endothelium; Free radical; Lipid peroxidation; Lipoproteins; Lipoxygenase; Monocytes; Myeloperoxidase; Nitr ic oxide; Peroxynitrite

Indexed keywords

ANTIOXIDANT; FREE RADICAL; LIPOPROTEIN; LIPOXYGENASE; LOW DENSITY LIPOPROTEIN; MYELOPEROXIDASE; NITRIC OXIDE;

ATHEROGENESIS; ATHEROSCLEROSIS; DIETARY INTAKE; ENDOTHELIUM; FOAM CELL; HYPERCHOLESTEROLEMIA; INFLAMMATION; IRON METABOLISM; LIPID PEROXIDATION; MONOCYTE; OXIDATION; PRIORITY JOURNAL; REVIEW; TRANSCRIPTION REGULATION; VASCULAR DISEASE;

EID: 0029883764     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/0891-5849(95)02173-6     Document Type: Review

References (265)

1. Parthasarathy, S.; Rankin, S. M. The role of oxidized LDL in atherogenesis. Prog. Lipid Res. 31:127-143; 1992.
2. Witzum, J. L.; Steinberg, D. Role of oxidized low density lipoprotein in atherogenesis. J. Clin. Invest. 88:1785-1792; 1991.
3. Berliner, J. A.; Navab, M.; Fogelman, A. M.; Frank, J. S.; Demer, L. L.; Edwards, P. A.; Watson, A. D.; Lusis, A. J. Atherosclerosis: Basic mechanisms: Oxidation, inflammation and genetics. Circulation 91:2488-2496; 1995.
4. Esterbauer, H.; Gebicki, J.; Puhl, H.; Jurgens, G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic. Biol. Med. 13:341-390; 1992.
5. Jessup, W.; Leake, D. S. Cell-mediated oxidation of lipoproteins. In: Rice-Evans, C.; Bruckdorfer, K. R., eds. Oxidative stress, lipoproteins and cardiovascular dysfunction, (in press).
6. Lynch, S. M.; Frei, B. Antioxidants as anti-atherogens: Animal studies. In: Frei, B., ed. Natural antioxidants in human health & disease. Orlando, FL; Academic Press; 1994.
7. Sevanian, A.; Hochstein, P. Mechanisms and consequences of lipid peroxidation in biological systems. Annu. Rev. Nutr. 5:365-390; 1985.
8. Halliwell, B.; Gutteridge, J. M. C.; Cross, C. E. Free radicals, antioxidants, and human disease: Where are we now? J. Lab. Clin. Med. 119:598-619; 1986.
9. Esterbauer, H.; Puhl, H.; Waeg, G.; Krebs, A.; Deiber-Rotheneder, M. The role of Vitamin E in lipoprotein oxidation. In: Packer, L.; Fuchs, J., eds. Vitamin E: Biochemistry and clinical application. New York: Marcel Dekker, Inc.; 1992:649-671.
10. Reaven, P. D.; Khoiow, A.; Beltz, W. F.; Parthasarathy, S.; Witztum, J. L. Effect of dietary antioxidant combinations in humans. Protection of LDL by vitamin E but not by beta carotene. Arterioscler Thromb. 13:590-600; 1993.
11. Esterbauer, H.; Striegl, G.; Puhl, H. The role of vitamin E and carotenoids in preventing oxidation of low density lipoproteins. Ann. NY Acad. Sci. 570:254-267; 1989.
12. Bowry, V. W.; Stocker, R. Tocopherol-mediated peroxidation - The prooxidant effect of vitamin E on the radical-initiated oxidation of human low-density lipoprotein. J. Am. Chem. Soc. 115:6029-6044; 1993.
13. Chait, A.; Brazg, R. L.; Tribble, D. L.; Krauss, R. M. Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B. Am. J. Med. 94:350-356; 1993.
14. Tribble, D. L.; Holl, L. G.; Wood, P. D.; Krauss, R. M. Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size. Atherosclerosis 93:189-99; 1992.
15. De Graaf, J.; Hak-Lemmers, H. L. M.; Hectors, M. P. C.; Denmacker, P. N. M.; Hendriks, J. C. M.; Stalenhoef, A. F. H. Enhanced susceptibility to in vitro oxidation of dense LDL subfraction in healthy subjects. Arterioscler Throm. 11:298-306; 1991.
16. Barakat, H. A.; Carpenter, J. W.; McLendon, V. D.; et al. Influence of obesity, impaired glucose tolerance, and NIDDM on LDL structure and composition; Possible link between hyperinsulinemia and atherosclerosis. Diabetes 39:1527-33; 1990.
17. Austin, M. A.; King, M.-C.; Fitch, W. L.; Krauss, R. M. Inheritance of low density lipoprotein subclass patterns in families with familial combined hyperlipidemia. Arteriosclerosis 10:520-30; 1990.
18. Williams, R. R.; Hunt, S. C.; Hopkins, P. N.; et al. Familial dyslipidemic hypertension. Evidence from 58 Utah families for a syndrome present in approximately 12% of patients with essential hypertension. JAMA 259:3579-86; 1988.
19. Tribble, D. L.; Krauss, R. M.; Lansberg, M. G.; Thiel, P. M.; van den Berg, J. J. M. Greater oxidative susceptibility of the surface monolayer in small dense LDL may contribute to differences in copper-induced oxidation among LDL density subfractions. J. Lipid Res. 36:662-671; 1995.
20. Cazzolato, G.; Avogaro, P.; Bittolo-Bon, G. Characterization of a more electronegatively charged LDL subfraction by ion exchange HPLC. Free Radic. Biol. Med. 11:247-253; 1991.
21. Shimano, H.; Yamada, N.; Ishibashi, S.; Mokuno, H.; Mori, N.; Gotoda, T.; Harada, K.; Akanuma, Y.; Murase, T.; Yazaki, Y.; Takaku, F. Oxidation-labile subfraction of human plasma low density lipoprotein isolated by ion-exchange chromatography. J. Lipid Res. 32:763-773; 1991.
22. Hodis, H. N.; Kramsch, D. M.; Avogaro, P.; Bittolo-Bon, G.; Cazzolato, G.; Hwang, J.; Peterson, H.; Sevanian, A. Biochemical and cytotoxic characteristics of an in vivo circulating oxidized low density lipoprotein (LDL-). J. Lipid Res. 35:669-677; 1994.
23. Lavy, A.; Brook, G. J.; Dankner, G.; Ben Amotz, A.; Aviram, M. Enhanced in vitro oxidation of plasma lipoproteins derived from hypercholesterolemic patients. Metabolism 40:794-799; 1991.
24. Hurt-Camejo, E.; Camejo, G.; Rosengren, B.; Lopez, I.; Wicklund, O.; Bondjers, G. Differential uptake of proteoglycan-selected subfractions of LDL by human macrophages. J. Lipid Res. 31:1382-1398; 1990.
25. Heinecke, J. W.; Rosen, H.; Chait, A. Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture. J. Clin. Invest. 74:1890-1894; 1984.
26. Morel, D. W.; DiCorleto, P. E.; Chisolm, G. M. Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation. Arteriosclerosis 4:357-364; 1984.
27. Steinbrecher, U. P.; Parthasarathy, S.; Leake, D. S.: Witztum, J. L.; Steinberg, D. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc. Natl. Acad. Sci. USA 81:3883-3887; 1984.
28. Ehrenwald, E.; Chisolm, G. M.; Fox, P. L. Intact ceruloplasmin oxidatively modifies low density lipoprotein. J. Clin. Invest. 93:1493-1501; 1994.
29. Balla, G.; Eaton, J. W.; Belcher, J. D.; Vercellotti, G. M. Hemin: A possible physiological mediator of low density lipoprotein oxidation and endothelial injury. Arterioscler. Thromb. 11:1700-1711; 1991.
30. Aasa, R.; Malmstrom, B. G.; Saltman, P.; Vanngard, T. The specific binding of iron (III) and copper (II) to transferrin and conalbumin. Biochem. Biophys. Acta 75:203-222; 1963.
31. Thomas, C. E. The influence of medium components on Cu-dependent oxidation of low density lipoproteins and its sensitivity to superoxide dismutase. Biochim. Biophys. Acta 1128:50-57; 1992.
32. Peters, T., Jr.; Blumenstock, F. A. Copper-binding properties of bovine serum albumin and its amino-terminal peptide fragment. J. Biol. Chem. 242:1574-1578; 1967.
33. Salonen, J. T.; Nyssonen, K.; Korpela, H.; Tuomilehto, J.; Salonen, R. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation 86:803-811; 1992.
34. Sempos, C. T.; Looker, A. C.; Gillum, R. F.; Makuc, D. M. Body iron stores and the risk of coronary heart disease. N. Engl. J. Med. 330:1119-1124; 1994.
35. Ascherio, A.; Willett, W. C. Are body iron stores related to the risk of coronary heart disease? N. Engl. J. Med. 330:1152-1154; 1994.
36. Bothwell, T. H.; Charlton, R. W.; Cook, J. D.; Finch, C. A. Iron metabolism in man. Oxford: Blackwell Scientific Pub.; 1979.
37. Smith, L. H. Overview of Hemochromatosis. West. J. Med. 153:296-308; 1990.
38. Grootveld, M.; Bell, J.; Halliwell, B.; Aruoma, O. I.; Bomford, A.; Sadler, P. J. Nontransferrin-bound iron in plasma and serum from patients with idiopathic hemochromatosis. J. Biol. Chem. 264:4417-4422; 1989.
39. Danks, D. M. Disorders of copper transport. In: Scriver, C. R.; Beaudet, A. L.; Sly, W. S.; Valley, D., eds. The metabolic basis of inherited disease, 6th ed. New York: McGraw-Hill, Inc.; 1989:1411-1422.
40. Van Lenten, B. J.; Prieve, J.; Navab, M.; Hama, S.; Lusis, A. J.; Fogelman, A. M. Lipid-induced changes in intracellular iron homeostasis in vitro and in vivo. J. Clin. Invest. 95:2104-2110; 1995.
41. Heinecke, J. W.; Baker, L.; Rosen, H.; Chait, A. Superoxide-mediated modification of low density lipoprotein by arterial smooth muscle cells. J. Clin. Invest. 77:757-761; 1986.
42. Heinecke, J. W.; Suzuki, L.; Rosen, H.; Chait, A. The role of sulfur containing amino acids in superoxide production and modification of low density lipoprotein by arterial smooth muscle cells. J. Biol. Chem. 262:10098-10103; 1987.
43. Misra, H. P. Generation of superoxide free radical during the autooxidation of thiols. J. Biol. Chem. 249:2151-2155; 1974.
44. Rowley, D. A.; Halliwell, B. Superoxide-dependent formation of hydroxyl radicals in the presence of thiol compounds. FEBS Lett. 138:33-36; 1982.
45. Tien, M.; Bucher, J. R.; Aust, S. D. Thiol-dependent lipid peroxidation. Biochem. Biophys. Res. Commun. 107:279-285; 1982.
46. Schoneich, C.; Dillinger, U.; Bruchhausen, F. V.; Asmus, K. D. Oxidation of polyunsaturated fatty acids and lipids through thiyl and sulfonyl radicals. Arch. Biochem. Biophys. 292:456-467; 1992.
47. Parthasarathy, S. Oxidation of low-density lipoprotein by thiol compounds lends to its recognition by the acetyl-LDL receptor. Biochim. Biophys. Acta 917:337-340; 1987.
48. Heinecke, J. W.; Kawamura, M.; Suzuki, L.; Chait, A. Oxidation of low density lipoprotein by thiols: Superoxide-dependent and -independent mechanisms. J. Lipid Res. 34:2051-2061; 1993.
49. Sparrow, C. P.; Olszewski, J. Cellular oxidation of LDL is caused by thiol production in media containing transition metal ions. J. Lipid Res. 34:1219-1228; 1993.
50. Mudd, S. H.; Levy, H. L.; Skovby, F. Disorders of transsulfuration. In: Scriver, C. R.; Beaudet, A. L.; Sly, W. S.; Valley, D., eds. The metabolic basis of inherited disease. New York: McGraw-Hill; 1989:793-743.
51. Harker, L. A.; Ross, R.; Slichter, S. J.; Scott, C. R. Homocystine-induced arteriosclerosis. J. Clin. Invest. 58:731-741; 1976.
52. Dudman, N. P. D.; Wilcken, D. E. L.; Stocker, R. Circulating lipid hydroperoxide levels in human homocysteinemia. Arterioscler. Thromb. 13:512-516; 1993.
53. Starkebaum, G.; Harlen, J. M. Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. J. Clin. Invest. 77:1370-1376; 1986.
54. Hiramatsu, K.; Rosen, H.; Heinecke, J. W.; Wolfbauer, G.; Chait, A. Superoxide initiates oxidation of LDL by human monocytes. Arteriosclerosis 7:55-60; 1987.
55. Cathcart, M. K.; McNally, A. K.; Morel, D. W.; Chisolm, G. M. Superoxide anion participation in human monocyte-mediated oxidation of LDL and conversion of LDL to a cytotoxin. J. Immunol. 142:1963-1969; 1989.
56. Steinbrecher, U. P. Role of superoxide in endothelial cell modification of LDL Biochim. Biophys. Acta 959:20-30; 1988.
57. Bedwell, S. R.; Dean, T.; Jessup, W. The action of defined oxygen-centered radicals on human low-density lipoprotein. Biochem. J. 262:707-712; 1989.
58. Rabini, J.; Klug-Roth, D.; Lilie, J. Pulse radiolytic investigations of the catalyzed disproportionation of peroxy radicals. Aqueous cupric ions. J. Phys. Chem. 77:1169-1175; 1973.
59. Jessup, W.; Simpson, J. A.; Dean, R. T. Does superoxide radical have a role in macrophage mediated oxidative modification of LDL? Atherosclerosis 99:107-120; 1993.
60. Lynch, S. M.; Frei, B. Mechanisms of copper- and iron-dependent oxidative modification of low density lipoprotein. J. Lipid Res. 34:1745-1753; 1993.
61. Yamamoto, S. Mammalian lipoxygenases: Molecular structures and functions. Biochim. Biophys. Acta 1128:117-131; 1992.
62. Belkner, J.; Wiesner, R.; Rathman, J.; Barnett, J.; Sigal, E.; Kuhn, H. Oxygenation of lipoproteins by mammalian lipoxygenases. Eur. J. Biochem. 213:251-261; 1993.
63. Kuhn, H.; Belkner, J.; Suzuki, H.; Yamamoto, S. Oxidative modification of human lipoproteins by lipoxygenases of different positional specificities. J. Lipid Res. 35:1749-1759; 1994.
64. Mather, S. N.; Field, F. J.; Spector, A. A. Increased production of lipoxygenase products by cholesterol-rich mouse macrophages. Biochim. Biosphys. Acta 837:13-19; 1985.
65. Sparrow, C. P.; Parthasarathy, S.; Steinberg, D. Enzymatic modification of LDL by purified lipoxygenase plus phospholipase A2 mimics cell-mediated oxidative modification. J. Lipid Res. 29:745-753; 1988.
66. Parthasarathy, S.; Weiland, E.; Steinberg, D. A role for endothelial cell lipoxygenase in the oxidative modification of low density lipoprotein. Proc. Natl. Acad. Sci. USA 86:1046-1050; 1989.
67. Jessup, W.; Darley-Usmar, V.; O'Leary, V.; Bedwell, O. S. 5-Lipoxygenases is not essential for macrophage mediated oxidation of LDL. Biochem. J. 278:163-169; 1991.
68. Sparrow, C. P.; Olszewski, J. Cellular oxidative modification of LDL does not require lipoxygenases. Proc. Natl. Acad. Sci. USA 89:128-131; 1992.
69. Yla-Herttuala, S.; Rosenfield, M. E.; Parthasarathy, S.; Carew, T. E.; Butler, S.; Witztum, J. L.; Steinberg, D. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J. Clin. Invest. 84:1086-1095; 1989.
70. Kuhn, H.; Belkner, J.; Zaiss, S.; Fahrenklemper, T.; Wohlfeil, S. Involvement of 15-lipoxygenase in early stages of atherogenesis. J. Exp. Med. 179:1903-1911; 1994.
71. Conrad, D. J.; Kuhn, H.; Mulkins, M.; Highland, E.; Sigal, E. Specific inflammatory cytokines regulate the expression of human monocyte 15-lipoxygenase. Proc. Natl. Acad. Sci. USA 89:217-221; 1992.
72. Yla-Herttuala, S.; Rosenfeld, M. E.; Parthasarathy, S.; Sigal, E.; Sarkioia, T.; Witztum, J. L.; Steinberg, D. Colocalization of 15-lipoxygenase mRNA and protein with epitopes of oxidized low density lipoprotein in macrophage-rich areas of atherosclerotic lesions. Proc. Natl. Acad Sci. USA 87:6959-6963; 1987.
73. Baynes, J. W. Role of oxidative stress in development of complications in diabetes. Diabetes 40:405-412; 1991.
74. Sakurai, T.; Kimura, S.; Nakano, M.; Kimura, H. Oxidative modification of glycated low density lipoprotein in the presence of iron. Biochem. Biophys. Res. Commun. 177:433-39; 1991.
75. Hunt, J. V.; Smith, C. C. T.; Wolf, S. P. Autooxidative glycosylation and possible involvement of peroxides and free radicals in LDL modification by glucose. Diabetes 39:1420-1424; 1990.
76. Kawamura, M.; Heinecke, J. W.; Chait, A. Pathophysiologic concentrations of glucose promote oxidative modification of LDL by a superoxide dependent pathway. J. Clin. Invest. 94:771-820; 1994.
77. Bucala, R.; Makita, Z.; Koschinsky, T.; Cerami, A.; Vlassara, H. Lipid advanced glycosylation: Pathway for lipid oxidation in vivo. Proc. Natl. Acad. Sci. USA 90:6434-6438; 1993.
78. Chisolm, G.; Irwin, K. C.; Penn, M. S. Lipoprotein oxidation and lipoprotein-induced cell injury in diabetes. Diabetes 41:61-66; 1992.
79. Morel, D. W.; Chisolm, G. M. Antioxidant treatment of diabetic rats inhibits lipoprotein oxidation and cytotoxicity. J. Lipid Res. 30:1827-34; 1989.
80. Higuchi, Y. Lipid peroxides and α-tocopherol in rat streptozotozin induced diabetes. Acta Med. Osayama 3:165-175; 1982.
81. Moncada, S.; Palmer, R. M.; Higgs, E. A. Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmacol. Rev. 43:109-142; 1991.
82. Jessup, W.; Mohr, D.; Gieseg, S. P.; Dean, R. T.; Stocker, R. The participation of nitric oxide in cell free and its restriction of macrophage-mediated oxidation of LDL. Biochim. Biophys. Acta 1180:73-82; 1992.
83. Beckman, J. S.; Beckman, T. W.; Chen, J.; Marshall, P. A.; Freeman, B. A. Apparent hydroxyl radical production by peroxynitrate: Implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. USA 87:1620-1624; 1990.
84. Darley, V. S.; Mar, V. M.; Hogg, H.; O'Leary, V. J.; Moncada, S. The simultaneous generation of superoxide and nitric oxide can initiate lipid peroxidation in human LDL. Free Radic. Res. Commun. 17:19-26; 1992.
85. Radi, R.; Beckman, J. S.; Bush, K. M.; Freeman, B. A. Peroxy nitrite-induced membrane lipid peroxidation: The cytotoxic potential of superoxide and nitric oxide. Arch. Biochem. Biophys. 288:481-487; 1991.
86. Graham, A. N.; Hogg, N.; Kalyanaraman, B.; O'Leary, V.; Darley Usmar, V.; Moncada, S. Peroxiynitirite modification of LDL leads to recognition by the macrophage scavenger receptor. FEBS 330:181-185; 1993.
87. Chang, G. J.; Woo, P.; Honda, H. H.; Ignarro, L. J.; Berliner, J. A.; Demer, L. L. Oxidation of LDL to a biologically active form by nitric oxide and nitrite and in the absence of superoxide-dependence on pH and oxygen. Arterioscler. Thromb. 14:1808-1814; 1994.
88. Ischiropoulos, H.; Ling, Z.; Chen, J.; Tsai, M.; Martin, J. C.; Smith, C. D.; Beckman, J. S. Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase. Arch. Biochem. Biophys. 298:431-437; 1992.
89. Beckmann, J. S.; Ye, Y. Z.; Anderson, P. G.; Chen, J.; Accavitti, M. A.; Tarpey, M. M.; White, C. R. Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biol. Chem. Hoppe-Seyler 375:81-88; 1994.
90. Yates, M. T.; Lambert, L. E.; Whitten, J. P.; MacDonald, I.; Mano, M.; Ku, G.; Mao, S. J. T. A protective role for nitric oxide in oxidative modification of LDL by mouse macrophages. FEBS Lett. 309:135-138; 1992.
91. Hogg, N.; Kalyanaraman, B.; Joseph, J.; Struck, A.; Parthasarathy, S. Inhibition of LDL oxidation by nitric oxide: Potential role in atherogenesis. FEBS Lett. 334:170-174; 1993.
92. Cooke, J. P.; Tsao, P. S. Is NO an endogenous antiatherogenic molecule? Arterioscler. Thromb. 14:653-655; 1994.
93. Klebanoff, S. F. Oxygen metabolism and the toxic properties of phagocytes. Ann Int. Med. 93:480-489; 1980.
94. Harrison, J. E.; Schultz, J. Studies on the chlorinating activity of myeloperoxidase. J. Biol. Chem. 251:1371-1374; 1976.
95. Heinecke, J. W.; Li, W.; Daehnke, H. L.; Goldstein, J. A. Dityrosine, a specific marker of oxidation, is synthesized by the myeloperoxidase-hydrogen peroxide system of human neutrophils and macrophages. J. Biol. Chem. 268:4069-4077; 1993.
96. Savenkova, M. I.; Mueller, D. M.; Heinecke, J. W. Tyrosyl radical generated by myeloperoxidase is a physiological catalyst for initiation of lipid peroxidation in low density lipoprotein. J. Biol. Chem. 269:20394-20400; 1994.
97. Hazell, L. J.; Stocker, R. Oxidation of low-density lipoprotein with hypochlorite causes transformation of the lipoprotein into a high-uptake form for macrophages. Biochem. J. 290:165-172; 1993.
98. Hazell, L. J.; VanDenBerg, J. J. M.; Stocker, R. Oxidation of low-density lipoprotein by hypochlorite causes aggregation that is mediated by modification of lysine residues rather than by lipid oxidation. Biochem. J. 302:293-304; 1994.
99. Wieland, E.; Parthasarathy, S.; Steinberg, D. Peroxidase-dependent metal independent oxidation of LDL in vitro: A model for in vivo oxidation? Proc. Natl. Acad. Sci. USA 90:5929-5933; 1993.
100. Heinecke, J. W.; Li, W.; Francis, G. A.; Goldstein, J. A. Tyrosyl radical generated by myeloperoxidase catalyzes the oxidative cross-linking of proteins. J. Clin. Invest. 91:2866-2872; 1993.
101. Francis, G. A.; Mendez, A. J.; Bierman, E. L.; Heinecke, J. W. Oxidative tyrosylation of high density lipoprotein by peroxidase enhances cholesterol removal from cultured fibroblasts and macrophage foam cells. Proc. Natl. Acad. Sci. USA 90:6631-6635; 1993.
102. Daugherty, A.; Zweifel, B. S.; Sobel, B. E.; Schonfeld, G. Isolation of low density lipoprotein from atherosclerotic vascular tissue of Watanabe heritable hyperlipidemic rabbits. Arteriosclerosis 8:768-777; 1988.
103. Winterbourn, C. C.; Vandenberg, J. J. M.; Roitman, E.; Kuypers, F. A. Chlorohydrin formation from unsaturated fatty acids reacted with hypochlorous acid. Arch. Biochem. Biophys. 296:547-555; 1992.
104. Heinecke, J. W.; Li, W.; Mueller, D. M.; Bohrer, A.; Turk, J. Cholesterol chlorohydrin synthesis by the myeloperoxidase-hydrogen peroxide-chloride system: Potential markers for lipoproteins oxidatively damaged by phagocytes. Biochemistry 33:10127-10136; 1994.
105. Daugherty, A.; Rateri, D. L.; Dunn, J. L.; Heinecke, J. W. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J. Clin. Invest. 94:437-444; 1994.
106. Rosenfeld, M. E.; Palinski, W.; Yla Herrtuala, S.; Butler, S.; Witztum, J. L. Distribution of oxidation specific lipid-protein adducts and apolipoprotein B in atherosclerotic lesions of varying severity from WHHL rabbits. Arterioscler. Thromb. 10:336-339; 1990.
107. Berliner, J. A.; Gerrity, R. G. Pathology of atherogenesis. In: Lusis, A. L.; Rotter, J. I.; Sparkes, R. S., eds. Molecular genetics of coronary artery disease. 1992:1-15.
108. Ross, R. The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 362:801-809; 1993.
109. Fuster, V.; Badimon, L.; Badimon, J.; Chesebro, J. H. The pathogenesis of coronary artery disease and the acute coronary syndromes. N. Engl. J. Med. 326:242-250; 1992.
110. Verbeuren, T. J.; Jordaens, F. H.; Zonnekeyn, L. L.; VanHove, C. E.; Coene, M. C.; Herman, A. G. Effect of hypercholesterolemia on vascular reactivity in the rabbit. Circ. Res. 58:552-564; 1986.
111. Cohen, R. A.; Zitnay, K. M.; Haudenschild, C. C.; Cunningham, R. D. Loss of selective endothelial cell vasoactive functions caused by hypercholesterolemia in pig coronary arteries. Circ. Res. 69:903-910; 1988.
112. Shimokawa, H.; Flavahan, N. A.; Vanhoutte, P. M. Loss of endothelial pertussis toxin-sensitive G-protein function in atherosclerotic porcine coronary arteries. Circulation 83:652-660; 1991.
113. Kugiyama, K.; Kerns, S. A.; Morrisett, J. D.; Roberts, R.; Henry, P. D. Impairment of endothelium-dependent relaxation by lyso-lecithin in modified LDL. Nature 344:160-162; 1990.
114. Galle, J.; Mulsch, A.; Busse, R.; Bassenge, E. Effects of native and oxidized low density lipoproteins on formation and inactivation of endothelium-derived relaxing factor. Arterioscler. Thromb. 11:198-203; 1991.
115. Flavahan, N. A.; Lysophosphatidylcholine modifies G protein-dependent signaling in porcine endothelial cells. Am. Physiol. Soc. 264:H722-H727; 1993.
116. Liao, J. K.; Clark, S. L. Regulation of G-protein alpha 12 subunit expression by oxidized LDL. J. Clin. Invest. 95:1457-1463; 1995.
117. White, C. R.; et al. Superoxide and peroxynitrite in atherosclerosis. Proc. Natl. Acad. Scid. USA 91:1044-1048; 1994.
118. Ohara, Y.; Peterson, T. E.; Harrison, D. G. Hypercholesterolemia increases endothelial superoxide anion production. J. Clin. Invest. 91:2546-2551; 1993.
119. Boulanger, C. M.; Tanner, P. C.; Dea, M. I.; Hahn, A. W. A.; Werner, A.; Luscher, T. F. Oxidized LDL induce mRNA expression and release of endothelin from human and porcine endothelium. Circ. Res. 70:1191-1197; 1992.
120. Gopaul, N. K.; Nourooz-Zadeh, J.; Mallet, A. I.; Anggard, E. E. Formation of PGF2-isoprostanes during the oxidative modification of low density lipoprotein. Biochem. Biophys. Res. Commun. 200:338-343; 1994.
121. Lynch, S. M.; Morrow, J. D.; Robert, K. J.; Frei, B. Formation of noncyclooxygenase-derived prostanoids (F2-isoprostanes) in plasma and low density lipoprotein exposed to oxidative stress in vitro. J. Clin. Invest. 93:998-1004; 1994.
122. Banerjee, M.; Kang, K. H.; Morrow, J. D.; Roberts, L. J.; Newman, J. H. Effects of a novel prostaglandin, 8-epi-PGF2, in rabbit lung in situ. Am. J. Physiol. 263:H660-H663; 1992.
123. Fukunaga, M.; Takahashi, K.; Badr, K. F. Vascular smooth muscle actions and receptor interactions of 8-iso-prostaglandin E2, an E2-isoprostane. Biochem. Biophys. Res. Commun. 195:507-515; 1993.
124. Meyers, P. R.; Wright, T. F.; Tanner, M. A.; Ostlund, R. E. The effects of native LDL and oxidized LDL on EDRF bioactivity and nitric oxide production in vascular endothelium. J. Lab. Clin. Med. 124:672-683; 1994.
125. Zeiher, A. M.; Drexler, H.; Wollschlager, H.; Just, H. Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation 83:391-401; 1991.
126. Drexler, H.; Zeiher, A. M.; Meinzer, K.; Just, H. Correction of endothelial dysfunction in the coronary microcirculation of hypercholesterolemic patients by L-arginine. Lancet 338:1546-1550; 1991.
127. Keaney, J. F.; Gaziano, J. M.; Xu, A.; Frei, B.; Curran-Celentano, J. C.; Shwaery, G. T.; Loscalzo, J.; Vita, J. A. Dietary antioxidants preserve endothelium dependent vessel relaxation in cholesterol-fed rabbits. Proc. Natl. Acad. Sci. USA 90:11880-11884; 1993.
128. Anderson, T. J.; Meredith, I. T.; Yeung, A. C.; Frei, B.; Selwyn, A. P.; Ganz, P. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N. Engl. J. Med. 332:488-493; 1995.
129. Butcher, E. C. Leukocyte-endothelial cell recognition: Three (or more) steps to specificity and diversity. Cell 67:1033-1036; 1991.
130. McEver, R. P, Leukocyte-endothelial cell interactions. Curr. Opin. Cell Biol. 4:840-849; 1992.
131. Berliner, J. A.; Territo, M. C.; Sevanian, A.; Ramin, S.; Kim, J. A.; Bamshad, B.; Esterson, M.; Fogelman, A. M. Minimally modified LDL stimulates monocyte endothelial interactions. J. Clin. Invest. 85:1260-1266; 1990.
132. Kim, J. A.; Territo, M. C.; Wayner, E.; Carlos, T. M.; Parhami, F.; Smith, C. W.; Haberland, M. E.; Fogelman, A. M.; Berliner, J. A. Partial characterization of Leukocyte binding molecules on endothelial cells induced by minimally oxidized LDL. Arterioscler. Thromb. 14:427-433; 1994.
133. Cushing, S. D.; Berliner, J. A.; Valente, A. J.; Territo, M. C.; Navab, M.; Parhami, F.; Gerrity, R.; Schwartz, C. J.; Fogelman, A. M. Minimally modified LDL induces monocyte chemotactic proteins I in human endothelial and smooth muscle cells. Proc. Natl. Acad. Sci. USA 87:5134-5138; 1990.
134. Rajavasisth, T. B.; Andalibi, A.; Territo, M. C.; Berliner, J. A.; Navab, M.; Fogelman, A. M.; Lusis, A. J. Modified LDL induce endothelial cell expression of granulocyte and macrophage colony stimulation factors. Nature 344:254-257; 1990.
135. Schwartz, D.; Chaverri-Almada, L.; Berliner, J. A.; Kirchgessner, T.; Quismorio, D. C.; Fang, Z. T.; Tekamp-Olson, P.; Lusis, A. J.; Fogelman, A. M.; Territo, M. C. The role of a grohomologue in monocyte adhesion to the endothelium. J. Clin. Invest. 94:1068-1973; 1994.
136. Watson, A. D.; Navab, M.; Hama, S. Y.; Sevanian, A.; Prescott, S. M.; Stafforini, D. M.; McIntyre, T. M.; La Du, B. N.; Fogelman, A. M.; Berliner, J. A. Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized LDL. J. Clin. Invest. 95:774-782; 1995.
137. Pritchard, K. A.; Tota, R. R.; Stemerman, M. D.; Wong, P. Y. 14, 15 Epoxyeicosatrienoic acid promotes endothelial cell dependent adhesion of human monocytic tumor U937 cells. Biochem. Biophys. Res. Commun. 167:137-142; 1989.
138. Clinton, S. K.; Underwood, R.; Hayes, I.; Sherman, M. I.; Kufe, D. W.; Libby, P. Macrophage colony stimulating factor gene expression in vascular cells and in experimental and human atherosclerosis. Am. J. Pathol. 140:301-316; 1992.
139. Rosenfeld, M. E.; Yla-Herttuala, S.; Lipton, B. A.; Ord, V. A.; Witztum, J. L.; Steinberg, D. Macrophage colony-stimulating factor mRNA and protein in atherosclerotic lesions of rabbits and humans. Am. J. Pathol. 140:291-300; 1992.
140. Yla-Herttuala, S.; Lipton, B. A.; Rosenfeld, M. E.; Sarkioja, T.; Yoshimura, T.; Leonard, E. J.; Witztum, J. L.; Steinberg, D. Macrophages express monocyte chemotactic protein (MCP-1) in human and rabbit atherosclerotic lesions. Proc. Natl. Acad. Sci. USA 88:5252-5256; 1991.
141. Cybulsky, M. I.; Gimbrone. M. A., Jr. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 251:788-791; 1991.
142. Khan, B. V.; Parthasarathy, S.; Alexander, R. W.; Medford, R. M. Modified LDL and its constituents augment cytokine-activated vascular cell adhesion molecule-1 gene expression in human vascular endothelial cells. J. Clin. Invest. 95:1262-1270; 1995.
143. Li, H.; Cybulsky, M. I.; Gimbrone, M. A., Jr.; Libby, P. An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium. Arterioscler. Thromb. 13:197-204; 1993.
144. O'Brien, K. D.; Allen, M. D.; McDonald, T. O.; Chait, A.; Harlan, J. M.; Fishbein, D.; McCarty, J.; Ferguson, M.; Hudkins, K.; Benjamin, C. D.; Lobb, R.; Alpers, C. E. VCAM-1 is expressed in human coronary atherosclerotic plaques. J. Clin. Invest. 92:945-951; 1993.
145. Calderon, T. M.; Factor, S. M.; Hatcher, V. B.; Berliner, J. A.; Berman, J. S. An endothelial cell adhesion protein for monocytes recognized by monoclonal antibody IG9. Expression in vivo in inflamed human vessels and atherosclerotic human and Watanabe rabbits. Lab. Invest. 70:836-841; 1994.
146. Lehr, H. A.; Seemuller, J.; Hubner, C.; Menger, M. D.; Messmer, K. Oxidized LDL induced leucocyte-endothelium interaction in vivo involves the receptor for platelet-activating factor. Arterioscler. Thromb. 13:1013-1018; 1993.
147. Gebuhrer, V.; Murphy, J. F.; Bordet, J.-C.; Reck, M.-P.; McGregor, J. L. Oxidized low-density lipoprotein induces the expression of P-selectin (GMP140/PADGEM/CD62) on human endothelial cells. Biochem. J. 306:293-298; 1995.
148. Johnson, R. R. L.; Mcgregor, P. R.; Taylor, R. N.; Poston, R. N. Increase in the adhesion molecule P-selectin in endothelium overlying atherosclerosis plaques - Coexpression with intercellular adhesion molecule-1. Am. J. Pathol. 144:952-961; 1994.
149. Quinn, M. T.; Parthasarathy, S.; Steinberg, D. Lysophosphatidyl choline: A chemotactic factor for human monocytes and its potential role in atherogenesis. Proc. Natl. Acad. Sci. USA 85:2805-2809; 1988.
150. Schmidt, A. M.; Yan, S. D.; Brett, J.; Mora, R.; Nowygrod, R.; Stern, D. Regulation of mononuclear phagocyte migration by cell surface bonding proteins for advanced glycosylation end products. J. Clin. Invest. 92:2155-2168; 1993.
151. Kirstein, M.; Brett, J.; Kadoff, S.; Ogawa, S.; Stern, D.; Vlassara, H. Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of PDGF: Role in vascular diseases of diabetes and aging. Proc. Natl. Acad. Sci. USA 87:9010-9014; 1990.
152. Yan, S. D.; Schmidt, A. M.; Andersons, G. M.; Zhang, J.; Brett, J.; Zou, Y. S.; Pinsky, D.; Stern, D. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J. Biol. Chem. 269:9889-9897; 1994.
153. Naruse, K.; Shimizu, K.; Muramatsu, M.; Toki, Y.; Miyazaki, Y.; Okumura, K.; Hashimoto, H.; Ito, T. Long term inhibition of NO synthesis promotes atherosclerosis in the hypercholesterolemic rabbit thoracic aorta. Arterioscler. Thromb. 14:746-752; 1994.
154. Cayette, A. J.; Palacino, J. J.; Horten, K.; Cohen, R. A. Chronic inhibition of nitric oxide production accelerates neointima formation and impairs function in hypercholesterolemic rabbits. Arterioscler. Thromb. 14:743-759; 1994.
155. Cooke, J. P.; Singer, A. H.; Tsao, P.; Zera, P.; Rowan, R. A.; Billingham, M. E. Antiatherogenic effects of L-argenine in the hypercholesterolemic rabbit. J. Clin. Invest. 90:1168-1172; 1992.
156. Hansson, G. K.; Holm, J.; Jonasson, L. Detection of activated T lymphocytes in the human atherosclerotic plaque. Am. J. Pathol. 135:160-175; 1989.
157. Palinski, W.; Ord, V. A.; Plump, A. S.; Breslow, J. L.; Steinberg, D. S.; Witztum, J. L. Apo E deficient mice are a model of LDL oxidation in atherogenesis-demonstration of oxidation specific epitopes in lesions and high titer of autoantibodies to MDA-LDL in serum. Arterioscler. Thromb. 14:605-616; 1994.
158. Palinski, W.; Miller, E.; Witztum, J. L. Immunization of LDL receptor deficient rabbits with MDA-LDL reduces atherogenesis. Proc. Natl. Acad. Sci. USA 32:821-825; 1995.
159. Fyfe, A. I.; Qiao, J.; Lusis, A. J. Immune-deficient mice develop typical atherosclerotic fatty streaks when fed an atherogenic diet. J. Clin. Invest. 94:2516-2560; 1994.
160. Haberland, M. E.; Steinbrecher, U. P. Modified low density lipoproteins: Diversity and biological relevance in atherogenesis. In: Lusis, A. J.; Rotter, J. I.; Sparkes, R. S., eds. Molecular genetics of coronary artery disease, vol. 14. Basel: Karger; 1992:35-61.
161. Krieger, M.; Acton, S.; Ashkenas, J.; Pearson, A.; Penman, M.; Resnick, D. Molecular flypaper, host defence, and atherosclerosis. Structure, binding properties, and functions of macrophage scavenger receptors. J. Biol. Chem. 268:3546-3554; 1993.
162. Dejager, S.; Mietus-Synder, M.; Pitas, R. E. Oxidized low density lipoproteins bind to the scavenger receptor expressed by rabbit smooth muscle cells and macrophages. Arterioscler. Thromb. 13:371-378; 1993.
163. de Villiers, W. J. S.; Fraser, I. P.; Hughes, D. A.; Doyle, A. G.; Gordon, S. M-CSF selectively enhances macrophage scavenger receptor expression and function. J. Exp. Med. 180:705-709; 1994.
164. Li, H.; Freeman, M. W.; Libby, P. Regulation of smooth muscle cell scavenger receptor expression in vivo by atherogenic diets and in vitro by cytokines. J. Clin. Invest. 95:122-133; 1995.
165. Endemann, G.; Stanton, L. W.; Madden, K. S.; Bryant, C. M.; White, R. T.; Protter, A. A CD36 is a receptor for oxidized low density lipoprotein. J. Biol. Chem. 268:11811-11816; 1993.
166. Sambrano, G. R.; Parthasarathy, S.; Steinberg, D. Recognition of
167. Steinbrecher, U. P. Oxidation of human low density lipoprotein results in derivatization of lysine residues of apolipoprotein B by lipid peroxide decomposition products. J. Biol. Chem. 262:3603-3608; 1987.
168. Zhang, H. F.; Yang, Y. H.; Steinbrecher, U. P. Structural requirements for the binding of modified proteins to the scavenger receptor of macrophages. J. Biol. Chem. 268:5535-5542; 1993.
169. Hoff, H. F.; Whitaker, T. E.; O'Neil, J. Oxidation of low density lipoprotein leads to particle aggregation and altered macrophage recognition. J. Biol. Chem. 267:602-609; 1992.
170. Hazell, L. J.; Stocker, R. Oxidation of low-density lipoprotein with hypochlorite causes transformation of the lipoprotein into a high-uptake form for macrophages. Biochem. J. 290:165-172; 1993.
171. Suits, A. G.; Chait, A.; Aviram, M.; Heinecke, J. W. Phagocytosis of aggregated lipoprotein by macrophages: Low density lipoprotein receptor-dependent foam cell formation. Proc. Natl. Acad. Sci. USA 86:2713-2717; 1989.
172. Khoo, J.; Miller, E.; McLoughlin, P.; Steinberg, D. Enhanced macrophage uptakes of low density lipoprotein after self-aggregation. Arteriosclerosis 8:348-358; 1988.
173. Falcone, D. J.; Mated, N.; Shio, H.; Minick, R.; Fowler, S. D. Lipoprotein-heparin-fibronectin-denatured collagen complexes enhance cholesteryl ester accumulation in macrophages. J. Cell. Biol. 99:1266-1274; 1984.
174. Yla-Herttuala, S.; Palinski, W.; Butler, S. W.; Picard, S.; Steinberg, D.; Witztum, J. L. Rabbit and Human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL. Arterioscler. Thromb. 14:32-40; 1994.
175. Khoo, J. C.; Mill, E.; Pio, F.; Steinberg, D.; Wiztum, J. L. Monoclonal antibodies against LDL further enhance macrophage uptake of LDL aggregates. Arterioscler. Thromb. 11:1258-1266; 1992.
176. Steinbrecher, V. P.; Lougheed, M. Scavenger receptor-independent stimulation of cholesterol esterification in macrophage by LDL extracted from human aorta intima. Arterioscler. Thromb. 12:608-625; 1992.
177. Lougheed, M.; Zhang, H.; Steinbrecher, U. Oxidized low density lipoprotein is resistant to cathepsins and accumulates within macrophages. J. Biol. Chem. 266:14519-14525; 1991.
178. Jessup, W.; Mander, E. L.; Dean, R. T. The intracellular storage and turnover of apolipoprotein B of oxidized LDL in macrophages. Biochim. Biophys. Acta 1126:167-177; 1992.
179. Ross, R. The pathogenesis of atherosclerosis: A perspective for the 1990's. Nature 362:801-809; 1993.
180. Raines, E. W.; Ross, R. Smooth muscle cells and the pathogenesis of the lesions of atherosclerosis. Br. Heart J. Suppl. 69:30-37; 1993.
181. Kume, N.; Gimbrone, M. A., Jr. Lysophosphatidylcholine transcriptionally induces growth factor gene expression in cultured human endothelial cells. J. Clin. Invest. 93:907-911; 1994.
182. Stikorahm, A.; Hultgardnilsson, A.; Rengstrom, J.; Hamsten, A.; Nilsson, J. Native and oxidized LDL enhances production of PDFG-AA and the surface expression of PDGF receptors in cultured human smooth muscle cells. Arterioscler. Thromb. 12:1099-1109; 1992.
183. Nakano, T.; Raines, E. V.; Abraham, J. A.; Klagsburn, M.; Ross, R. Lysophosphatidylcholine induces monocyte expression of heparin binding EGF like growth factor mRNA. J. Cell. Biochem. Suppl. 16:18-24; 1992.
184. Ku, G.; Thomas, C. A.; Akeson, A. L.; Jackson, R. L. Induction of interleukin 1 beta expression from human peripheral blood monocyte-derived macrophages by 9-hydroxyoctadecadienoic acid. J. Biol. Chem. 267:14183-14188; 1992.
185. Thomas, C. E.; Jackson, R. L.; Ohlweiler, D. F.; Ku, G. Multiple lipid oxidation products in low density lipoproteins induce interleukin-1 beta release form human blood mononuclear cells. J. Lipid Res. 35:417-427; 1994.
186. Hamilton, T. A.; Major, J. A.; Chisolm, G. M. The effects of oxidized LDL on inducible macrophage gene expression are gene and stimulus dependent. J. Clin. Invest. 95:2020-2027; 1995.
187. Locher, R.; Weison, B.; Mengden, T.; Brunner, C.; Vetter, W. Lysolecithin action on vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 183:156-162; 1992.
188. Ross, R.; Masuda, J.; Raines, E. W.; et al. Localization of PDGF-B protein in macrophages in all phases of atherogenesis. Science 248:1009-1012; 1990.
189. Moyer, C. F.; Sajothi, D.; Eli, H.; Williams, J. K. Synthesis of EL-1 alpha and beta by arterial cells in atherosclerosis. Am. J. Pathol. 138:951-960; 1991.
190. Tipping, P. G.; Hancock, W. W. Production of TNF and IL-1 by macrophages from human atheromatous plaques. Am. J. Pathol. 142:1721-1728; 1993.
191. Seino, Y.; Ikeda, U.; Ikeda, M.; Yamamoto, K.; Misawa, Y.; Hasegawa, T.; Kano, S.; Shimaoa, K. IL-6 gene transcripts are expressed in human atherosclerotic lesions. Cytokine 6:87-91; 1993.
192. Miyagawa, J.; Higashiyama, S.; Kawata, S.; Inui, Y.; Tamura, S.; Yamamoto, K.; Nishida, M.; Nakamura, T.; Yamashita, S.; Matsuzawa, Y.; Taniguchi, N. Localization of heparin binding EGF-like growth factor with smooth muscle cells and macrophages of human atherosclerotic plaques. J. Clin. Invest. 95:404-411; 1995.
193. Lipay, M. J.; Parks, W. C.; Mecham, R. P.; Roby, J.; Kaiser, L. R.; Cooper, J. D.; Botney, M. D. Neointimal macrophages colocalize with extracellular matrix gene expression in human atherosclerotic pulmonary arteries. J. Clin. Invest. 91:588-594; 1993.
194. Gallis, Z. S.; Muzynski, M.; Sukhova, G. K.; Simon-Morrissey, F.; Unemori, E. N.; Lark, M. W.; Amenito, E.; Libby, P. Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzyme required for extracellular matrix digestion. Circ. Res. 75:181-189; 1994.
195. Henny, A. M.; Wakely, P. R.; Davies, M. J.; Hembry, R.; Murphy, G.; Humphries, S. Localization of stromelysin gene in atherosclerotic plaques using in situ hybridization. Proc. Natl. Acad. Sci. USA 88:8154-8158; 1991.
196. Galis, Z. S.; Sukhova, G. K.; Lark, M. W.; Libby, P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J. Clin. Invest. 94: 2493-2503; 1994.
197. Yui, S.; Sasaki, T.; Miyazake, A.; Horiuchi, S.; Yamazaki, M. Induction of murine macrophage growth by modified LDLs. Arterioscler. Thromb. 13:331-337; 1993.
198. Geng, Y.; Libby, P. Evidence for apoptosis in human atheroma: Colocalization with IL-1 beta converting enzyme. Am. J. Path. 147:251-256; 1995
199. Kosugi, K.; Morel, D. W.; DiCorleto, P. E.; Chisolm, G. M. Toxicity of oxidized low density lipoprotein to cultured fibroblasts is selective for the S phase of the cell cycle. J. Cell Physiol. 102:119-127; 1987.
200. Sevanian, A.; Berliner, J.; Peterson, H. Uptake, metabolism, and cytotoxicity of isomeric cholesterol-5,6-epoxides in rabbit aortic endothelial cells. J. Lipid Res. 32:147-156; 1991.
201. Hughes, H.; Matthews, B.; Lenz, M. L.; Guyton, J. R. Cytotoxicity of oxidized LDL to porcine aortic smooth muscle cells is associated with the oxysterols 7 ketochol7esterol and 7-hydroxycholesterol. Arterioscler. Thromb. 14:1177-1184; 1994.
202. Reid, V. C.; Mitchinson, M. J. Toxicity of oxidized LDL towards mouse peritoneal macrophages in vitro. Atherosclerosis 98:17-24; 1993.
203. Benedetti, A.; Comporti, M.; Esterbauer, H. Identification of 4-hydroxynonenal as a cytotoxic product originating from the peroxidation of liver microsomal lipids. Biochim. Biophys. Acta 620:281-296; 1980.
204. Negre-Salvayre, A.; Fitoussi, G.; Reaud, V.; Pieraggi, M.; Thiers, J.; Salvayre, R. A delayed and sustained rise of cytosolic calcium is elicited by oxidized LDL in cultured bovine aortic endothelial cells. FEBS 299:60-65; 1993.
205. Escargueil, I.; Negre-Salvayre, A.; Pieraggi, M. T.; Salvayre, R. Oxidized low density lipoproteins elicit DNA fragmentation of cultured lymphoblastoid cells. FEBS Lett. 05:155-159; 1992.
206. Demer, L. L.; Watson, K. E.; Bostrom, K. Mechanisms of calcification in atherosclerosis. Trends Cardiovasc. Med. 4:45-49; 1994.
207. Watson, K. E.; Bostrom, K.; Ravindranath, R.; Lam, T.; Norton, B.; Demer, L. L. TGFB1 and 25 hydroxycholesterol stimulate osteoblast-like vascular cells to calcify. J. Clin. Invest. 93:2106-2113; 1994.
208. Murugesan, G.; Chisolm, G. M.; Fox, P. L. Oxidized low density lipoprotein inhibits the migration of aortic endothelial cells in vitro. J. Cell Biol. 120:1011-1019; 1993.
209. Woolf, N.; Davies, M. J. Interrelationship between atherosclerosis and thrombosis. In: Fuster, V., ed. Verstreate meds thombosis in cardiovascular disorders. Philadelphia, PA: W. B. Saunders 1992:41-77.
210. Weis, J. R.; Pitas, R. E.; Wilson, B. D.; Rodgers, G. M. Oxidized LDL increases cultured human endothelial cell tissue factor activity and reduces protein C activation. FASEB J. 5:2459-2465; 1991.
211. Drake, T. A.; Hannani, K.; Fei, H.; Lavi, S.; Berliner, J. A. MM-LDL induces tissue factor expression in cultured human endothelial cells. Am. J. Pathol. 138:601-607.
212. Brand, L.; Banka, C. L.; Mackman, N.; Terkeltaub, R. A.; Fan, S.; Curtiss, L. K. Oxidized LDL entrance LPS induced tissue factor expression in adherent monocytes. Arterioscler. Thromb. 14:790-797; 1994.
213. Wilcox, J. N.; Smith, K. M.; Schwartz, S. M.; Gordon, D. Localization of tissue factor in the normal vessel and in the atherosclerotic plaque. Proc. Natl. Acad. Sci. USA 86:2839-2843; 1989.
214. Aviram, M. Modified forms of low density lipoprotein affect platelet aggregation in vitro. Thromb. Res. 53:561-567; 1989.
215. Naseem, K. M.; Goodall, A. H.; Bruckdorfer, K. R. The effects of native and oxidized low density lipoprotein on platelet activation. Biochem. Soc. Trans. 21:140S; 1993.
216. Stremler, K. E.; Stafforini, D. M.; Prescott, S. M.; McIntyre, T. M. Human plasma PAF-acetylhydrolase: Oxidatively fragmented phospholipids as substrates. J. Biol. Chem. 266(17):11095-11103; 1991.
217. Morrow, J. D.; Minton, T. A.; Roberts, L. J. The F2-isoprostane, 8-epi-prostaglandin F2 alpha, a potent agonist of the vascular thromboxane/endoperoxide receptor, is a platelet thromboxane/endoperoxide receptor antagonist. Prostaglandins 44:155-163; 1992.
218. Tipping, P. G.; Davenport, P.; Gallicchio, M.; Filonzi, E. L.; Apostolopoulos, J.; Wojta, J. Atheromatous plaque macrophages produce PAI-1 and stimulate its production by endothelial cells and smooth muscle cells. Am. J. Pathol. 143:875-885; 1993.
219. Parhami, F.; Fang, Z. T.; Fogelman, A. M.; Andalibi, A.; Territo, M. C.; Berliner, J. A. Minimally modified LDL induced inflammatory responses in endothelial cells are mediated by cyclic adensosine monophosphate. J. Clin. Invest. 92:471-478; 1993.
220. Sugiyama, S.; Kugiyama, K.; Ohgish, M.; Fujimoto, K.; Yasue, H. Lyso PC in oxidized LDL increases endothelial susceptibility to PMN induced endothelial dysfunction in porcine coronary arteries. Role of PKC. Circ. Res. 74:565-575; 1994.
221. Collins, T. Endothelial nuclear factor KB and the initiation of the atherosclerotic lesion. Lab. Invest. 5:599-608; 1993.
222. Rajavashisth, T. B.; Yamada, H.; Mishra, N. K. Transcriptional activation of the MCSF gene by minimally modified LDL: Involvement of NFkB. Arterioscler. Thromb. Vasc. Biol. 15:1591-1598; 1995.
223. Liao, F.; Andalibi, A.; Quiao, J. H.; Allayee, H.; Fogelman, A. M.; Lusis, A. J. Genetic evidence of a common pathway mediating oxidative stress, inflammatory gene induction and aortic fatty streak formation in mice. J. Clin. Invest. 94:877-884; 1994.
224. Schreck, R.; Rieber, P.; Baeverk, P. A. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NKKB transcription factor and HIV-1. EMBO J. 10:2247-2258; 1991.
225. Suzuki, Y. S.; Packer, L. Inhibition of NFkB DNA binding activity by alpha tocopherol succinate. Biochem. Mol. Biol. Int. 31:693-700; 1993.
226. Peng, H.; Rajavashisth, T. B.; Libby, P.; Liao, J. K. Nitric oxide inhibits MCSF gene transcription in vascular endothelium. J. Biol. Chem. 270:17050-17055; 1995.
227. Pritchard, K. A.; Groszek, L.; Smalley, D. M.; Sessa, W. C.; Wu, M.; Villanlon, P.; Wolin, M. S.; Stemerman, M. B. Native LDL increases endothelial cell nitric oxide synthase generation of superoxide anion. Circ. Res. 77:510-518; 1995.
228. Zhang, H.; Davis, W. B.; Chen, X.; Jones, K. H.; Whisler, R. L.; Cornwell, D. G. Effects of oxidized LDL on arachidonic acid metabolism in smooth muscle cells. J. Lipid Res. 31:551-565; 1990.
229. Hessler, J. R.; Robertson, A. L.; Chisolm, G. M. LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in culture. Arteriosclerosis 32:213-229; 1979.
230. Parthasarathy, S.; Barnett, J.; Fong, L. J. High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein. Biochim. Biophys. Acta 1044:275-283; 1990.
231. Navab, M.; Imes, S. S.; Hama, S. Y.; Hough, G. P.; Ross, L. A.; Bork, R. W.; Valente, A. J.; Berliner, J. A.; Drinkwater, D. C.; Laks, H.; Fogelman, A. M. Monocyte transmigration induced by modification of LDL in co-cultures of human aortic wall cells is due to induction of MCP-1 synthesis and is abolished by HDL. J. Clin. Invest. 88:2039-2046; 1991.
232. Maier, J. A. M.; Barenghi, L.; Pagani, F.; Bradamante, S.; Comi, P.; Ragnotti, G. The protective role of HDL on oxidized LDL induced U937 endothelial cell interaction. Eur. J. Biochem. 221:35-41; 1994.
233. La Du, B. N. Human serum paraoxonase/arylesterase. In: Kalow, W. ed. Pharmacology of drug metabolism. New York: Pergamon Press Inc.; 1992:51-91.
234. Furlong, C. E.; Richter, R. J.; Chapline, C.; Crabb, J. W. Purification of rabbit and human serum paraoxonase. Biochemistry 30:10133-10140; 1991.
235. Mackness, M. I.; Arrol, S.; Durrington, P. N. Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein. FEBS Lett. 286:152-154; 1991.
236. Mackness, M. I.; Arrol, S.; Abbott, C. A.; Durrington, P. N. Is paraoxonase related to atherosclerosis. Chem-Biol Interact. 87:161-171; 1993.
237. Watson, A. D.; Berliner, J. A.; Hama, S. Y.; La Du, B. N.; Faull, K. F.; Fogelman, A. M.; Navab, M. Protective effect of HDL associated paraoxonase - Inhibition of the biological activity of minimally oxidized LDL. J. Clin. Invest. 95:2882-2891; 1995.
238. Stafforini, D. M.; Zimmerman, T. M.; McIntyre, T. M. Prescott, S. M. The platelet activating factor acetylhydrolase from human plasma prevents oxidative modification of low density lipoprotein. Trans. Am. Assoc. Phys. 106:44-63; 1993.
239. Steinbrecher, U. P.; Prichard, P. H. Hydrolysis of phosphatidyl choline during LDL oxidation is mediated by PAF acetyl hydrolase. J. Lipid Res. 30:305-315; 1989.
240. Xu, Q.; Buhler, E.; Steinmetz, A.; Schonitzer, D.; Bock, G.; Jurgens, G.; Wick, G. A high-density-lipoprotein receptor appears to mediate the transfer of essential fatty acids from high-density lipoprotein to lymphocytes. Biochem. J. 287:395-401; 1992.
241. Bowry, V. W.; Stanley, K. K.; Stocker, R. High density lipoprotein is the major carrier of lipid hydroperoxides in human blood plasma from fasting donors. Proc. Natl. Acad. Sci. USA 89:10316-10320; 1992.
242. Sattler, W.; Stocker, R. Greater selective uptake by Hep G2 cells of high density lipoprotein cholesteryl ester hydroperoxides than of unoxidized cholesteryl esters. Biochem. J. 294: 771-778; 1993.
243. Parthasarathy, S.; Young, S. G.; Witztum, J. L.; Pittman, R. C.; Steinberg, D. Probucol inhibits oxidative modification of low density lipoprotein. J. Clin. Invest. 77:641-644; 1986.
244. Carew, T. E.; Schwenke, D. C.; Steinberg, D. Antiatherogenic effect of probucol unrelated to its hypercholesterolemic effect: Evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit. Proc. Natl. Acad. Sci. USA 84:7725-7729; 1987.
245. Kita, T.; Nagano, Y.; Yokode, M.; Ishi, K.; Kume, N.; Ooshima, A.; Yoshida, H.; Kawai, C. Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia. Proc. Natl. Acad. Sci. USA 84:5928-5931; 1987.
246. Mao, S. T. J.; Yates, M. T.; Parker, R. A.; Chi, E. M.; Jackson, R. L. Attenuation of atherosclerosis in a modified strain of hypercholesterolemic Watanabe rabbits with use of a probucol analogue (MDL 29,311) that does not lower serum cholesterol. Arteriosclerosis 11:1266-1275; 1991.
247. Sasahara, M.; Raines, E. W.; Chait, A.; Carew, T. E.; Steinberg, D.; Wahl, P. W.; Ross, R. Inhibition of hypercholesterolemia-induced atherosclerosis in nonhuman primate by probucol. I. Is the extent of atherosclerosis related to resistance of LDL to oxidation? J. Clin. Invest. 94:155-164; 1994.
248. Sparrow, C. P.; Deobber, T. W.; Olszewski, J.; Wu, M. S.; Ventre, J.; Stevens, K. A.; Chao, Y. S. Low density lipoprotein is protected from oxidation and the progression of atherosclerosis is slowed in cholesterol-fed rabbits by the antioxidant N,N′-diphenyl-phenylenediamine. J. Clin. Invest. 89:1885-1891; 1992.
249. Fruebis, J.; Steinberg, D.; Dresel, H. A.; Carew, T. E. A comparison of the antiatherogenic effects of probucol and of a structural analogue of probucol in low density lipoprotein receptor-deficient rabbits. J. Clin. Invest. 94:392-398; 1994.
250. Reavens, P. D.; Parthasarathy, S.; Belt, W. F.; Witztum, J. L. Effect of probucol dosage on plasma lipid and lipoprotein levels and on protection of low density lipoprotein against in vitro oxidation in humans. Arterioscler Thromb. 12:318-324; 1992.
251. Hara, S.; Nagano, Y.; Sasada, M.; Kita, T. Probucol pretreatment enhances the chemotaxis of mouse peritoneal macrophages. Arterioscler Thromb. 12:593-600; 1992.
252. McPherson, R.; Hogue, M.; Milne, R. W.; Tall, A. R.; Marcel, Y. L. Increase in plasma cholesteryl ester transfer protein during probucol treatment. Arterioscler. Thromb. 11:476-481; 1991.
253. Kleinveld, H. A.; Demacker, P. N. M.; Stalenhoef, A. F. H. Comparative study on the effect of low-dose vitamin E and probucol on the susceptibility of LDL to oxidation and the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbits. Arterioscler. Thromb. 14:1386-1391; 1994.
254. Daugherty, A.; Roselaar, S. E. Lipoprotein oxidation as a mediator of atherogenesis: Insights from pharmacological studies. Cardiol. Res. 29:297-311; 1995.
255. Nagano, Y.; Nakamura, T.; Matsuzawa, Y.; Mikimaro, C.; Ueda, Y.; Kita, T. Probucol and atherosclerosis in the Watanabe heritable hyperlipidemic rabbit - Long-term and antiatherogenic effect and effects on established plaques. Atherosclerosis 92:131-140; 1992.
256. Gaziano, J. M.; Hennekens, C. H. Vitamin antioxidants and cardiovascular disease. Curr. Opin. Lipidol. 3:291-294; 1992.
257. Stampfer, M.; Hennekens, C. H.; Manson, J. E.; Colditz, G. A.; Rosner, B.; Willett, W. C. Vitamin E consumption and the risk of coronary disease in women. N. Engl. J. Med. 328:1444-1489; 1993.
258. Rimm, E. B.; Stampler, M. J.; Ascherio, A.; Giovannuci, E.; Willett, G. A.; Colditz, W. C. Vitamin E consumption and the risk of coronary heart disease in men. N. Engl. J. Med. 328:1450-1456; 1993.
259. Dieber-Rotheneder, M.; Puhl, H.; Waeg, G.; Striegl, G.; Esterbauer, H. Effect of oral supplementation with D-alpha tocopherol on the vitamin E content of human low density lipoproteins and resistance to oxidation. J. Lipid Res. 32:1325-1332; 1991.
260. Jialal, I.; Grundy, S. The effect of dietary supplementation with alpha-tocopherol in the oxidative modification of low density lipoprotein. J. Lipid Res. 33:899-906; 1992.
261. Gey, K.; Preska, P.; Jordan, P.; Moser, U. Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross cultural epidemiology. Am. J. Clin. Nutr. 53:S326-S334; 1992.
262. Kardinaal, A. F. M.; Kok, F. K.; Ringstad, J.; Gomez-Aracena, J.; Mazaev, V. P.; et al. Antioxidants in adipose tissue and risk of myocardial infarction: The EURAMIC study. Lancet 342:1379-1384; 1993.
263. Wallidius, G.; Erikson, U.; Olsson, A. G.; Bergstrand, L.; Hadell, K.; et al. The effect of probucol on femoral atherosclerosis: The probucol quantitative regression. Swedish trial (PQRST). Am. J. Cardiol. 74:875-883; 1994.
264. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The Effect of Vitamin E and Beta Carotene on the Incidence of Lung Cancer and other Cancers in Male Smokers. N. Engl. J. Med. 330:1029-1035; 1994.
265. Bocan, T. M.; Mueller, S. B.; Brown, E. Q.; Uhlendorf, P. D.; Mazur, M. J.; Newton, R. S. Antiatherosclerotic effects of antioxidants are lesion-specific when evaluated in hypercholesterolemic New Zealand white rabbits. Exp. Mol. Pathol. 57:70-83; 1992.